General News | Nov. 14, 2016

Top Lupus Researchers Recognized For Exceptional Achievement

We're honored to announce the winners of this year's Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.

General News | Oct. 24, 2016

Announcing the Cut it Out Challenge: A Crowdfunding Campaign for Lupus

The LFA has launched a Crowdrise campaign to draw attention to the sacrifices people with lupus are forced to make.

Blog | Oct. 04, 2016

When Flares Happen

Reports that Toni Braxton was hospitalized for complications from lupus are a reminder that people with lupus experience disease flares that can be triggered by environmental factors like stress or exhaustion.

General News | Sep. 07, 2016

Free Yourself From Pain… It’s Pain Awareness Month

Pain is cited as the most common reason Americans access the health care system.

General News | Aug. 31, 2016

With announcement, Selena Gomez highlights mental health impact of lupus

Anxiety and depression often accompany lupus, for a variety of reasons. It's important to learn the signs and when to seek treatment.

General News | Aug. 22, 2016

Mortality in Lupus: The Untold Story

We need accurate statistics on the incidence and prevalence of lupus and its associated rate of mortality and a much more robust public and private lupus research effort on lupus.

Research News | Aug. 15, 2016

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint

Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.

General News | Aug. 10, 2016

Access to Treatments

One of our key goals is to ensure people with lupus have access to the care and treatments they need. Recently, access to a few vital treatments has been challenging to obtain, specifically access to quinacrine, hydroxychloroquine, and Benlysta®.